Pfizer Urges Court Not To Ax Delay Defense In Vax IP Fight

By Adam Lidgett

Pfizer and BioNTech have urged a Delaware federal judge to reject GlaxoSmithKline's attempt to toss claims that the COVID-19 vaccine technology patents GSK is accusing them of infringing are unenforceable because of an unreasonable delay in obtaining them.

 Brief attached | Read full article » | Save to favorites »